Pelitinib
- Generic Name
- Pelitinib
- Drug Type
- Small Molecule
- Chemical Formula
- C24H23ClFN5O2
- CAS Number
- 257933-82-7
- Unique Ingredient Identifier
- X5DWL380Z6
Overview
Pelitinib (EKB-569) is a potent, low molecular weight, selective, and irreversible inhibitor of epidermal growth factor receptor (EGFR) that is being developed as an anticancer agent.
Background
Pelitinib (EKB-569) is a potent, low molecular weight, selective, and irreversible inhibitor of epidermal growth factor receptor (EGFR) that is being developed as an anticancer agent.
Indication
Investigated for use/treatment in colorectal cancer and lung cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath